Find LAE001 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Cfg920, Cfg-920, 1260006-20-9, Cfg920 [who-dd], Lae001, Up0k5026vb
Molecular Formula
C14H13ClN4O
Molecular Weight
288.73  g/mol
InChI Key
ZVIFCOOHWGNPHJ-UHFFFAOYSA-N
FDA UNII
UP0K5026VB

LAE001
CYP17/CYP11B2 Inhibitor LAE001 is an orally bioavailable, non-steroidal, potent, reversible, dual inhibitor of cytochrome P450 17 (CYP17 or CYP17A1) and CYP11B2, with potential antiandrogen and antineoplastic activities. Upon oral administration, LAE001 inhibits the enzymatic activity of CYP17A1 in both the testes and adrenal glands, thereby inhibiting androgen production. This may decrease androgen-dependent growth signaling and may inhibit cell proliferation of androgen-dependent tumor cells. LAE001 also inhibits the enzymatic activity of CYP11B2, thereby inhibiting aldosterone production. This may reduce the elevated aldosterone levels resulting from CYP17 inhibition and androgen deprivation, leading to a reduction in mineralocorticoid side effects including cardiovascular complications. The cytochrome P450 enzyme CYP17A1, localized to the endoplasmic reticulum, exhibits both 17alpha-hydroxylase and 17,20-lyase activities, and plays a key role in the steroidogenic pathway that produces steroidal hormones. The cytochrome P450 enzyme CYP11B2, aldosterone synthase, is an enzyme that plays a key role in aldosterone biosynthesis.
1 2D Structure

LAE001

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(2-chloropyridin-4-yl)-3-(4-methylpyridin-3-yl)imidazolidin-2-one
2.1.2 InChI
InChI=1S/C14H13ClN4O/c1-10-2-4-16-9-12(10)19-7-6-18(14(19)20)11-3-5-17-13(15)8-11/h2-5,8-9H,6-7H2,1H3
2.1.3 InChI Key
ZVIFCOOHWGNPHJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C=NC=C1)N2CCN(C2=O)C3=CC(=NC=C3)Cl
2.2 Other Identifiers
2.2.1 UNII
UP0K5026VB
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Cfg920

2. Cfg-920

3. 1260006-20-9

4. Cfg920 [who-dd]

5. Lae001

6. Up0k5026vb

7. Lae-001

8. 2-imidazolidinone, 1-(2-chloro-4-pyridinyl)-3-(4-methyl-3-pyridinyl)-

9. Unii-up0k5026vb

10. Schembl3780132

11. Chembl4297485

12. Bdbm132132

13. Bcp21188

14. Usre45173, 58a

15. Nsc787827

16. Nsc-787827

17. Sb18845

18. Db-097444

19. 1-(2-chloro-pyridin-4-yl)-3-(4-methyl-pyridin-3-yl)-imidazolidin-2-one

2.4 Create Date
2011-02-22
3 Chemical and Physical Properties
Molecular Weight 288.73 g/mol
Molecular Formula C14H13ClN4O
XLogP31.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass288.0777887 g/mol
Monoisotopic Mass288.0777887 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count20
Formal Charge0
Complexity367
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1260006-20-9 / LAE001 API manufacturers, exporters & distributors?

LAE001 manufacturers, exporters & distributors 1

15

PharmaCompass offers a list of LAE001 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LAE001 manufacturer or LAE001 supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LAE001 manufacturer or LAE001 supplier.

PharmaCompass also assists you with knowing the LAE001 API Price utilized in the formulation of products. LAE001 API Price is not always fixed or binding as the LAE001 Price is obtained through a variety of data sources. The LAE001 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

LAE001

Synonyms

Cfg920, Cfg-920, 1260006-20-9, Cfg920 [who-dd], Up0k5026vb, Lae-001

Cas Number

1260006-20-9

Unique Ingredient Identifier (UNII)

UP0K5026VB

About LAE001

CYP17/CYP11B2 Inhibitor LAE001 is an orally bioavailable, non-steroidal, potent, reversible, dual inhibitor of cytochrome P450 17 (CYP17 or CYP17A1) and CYP11B2, with potential antiandrogen and antineoplastic activities. Upon oral administration, LAE001 inhibits the enzymatic activity of CYP17A1 in both the testes and adrenal glands, thereby inhibiting androgen production. This may decrease androgen-dependent growth signaling and may inhibit cell proliferation of androgen-dependent tumor cells. LAE001 also inhibits the enzymatic activity of CYP11B2, thereby inhibiting aldosterone production. This may reduce the elevated aldosterone levels resulting from CYP17 inhibition and androgen deprivation, leading to a reduction in mineralocorticoid side effects including cardiovascular complications. The cytochrome P450 enzyme CYP17A1, localized to the endoplasmic reticulum, exhibits both 17alpha-hydroxylase and 17,20-lyase activities, and plays a key role in the steroidogenic pathway that produces steroidal hormones. The cytochrome P450 enzyme CYP11B2, aldosterone synthase, is an enzyme that plays a key role in aldosterone biosynthesis.

LAE001 Manufacturers

A LAE001 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LAE001, including repackagers and relabelers. The FDA regulates LAE001 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LAE001 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

LAE001 Suppliers

A LAE001 supplier is an individual or a company that provides LAE001 active pharmaceutical ingredient (API) or LAE001 finished formulations upon request. The LAE001 suppliers may include LAE001 API manufacturers, exporters, distributors and traders.

LAE001 GMP

LAE001 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of LAE001 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LAE001 GMP manufacturer or LAE001 GMP API supplier for your needs.

LAE001 CoA

A LAE001 CoA (Certificate of Analysis) is a formal document that attests to LAE001's compliance with LAE001 specifications and serves as a tool for batch-level quality control.

LAE001 CoA mostly includes findings from lab analyses of a specific batch. For each LAE001 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

LAE001 may be tested according to a variety of international standards, such as European Pharmacopoeia (LAE001 EP), LAE001 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LAE001 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty